Services for thalassaemia as a model for cost‐benefit analysis of genetics services
- 1 July 1991
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 14 (4), 640-651
- https://doi.org/10.1007/bf01797934
Abstract
Economic appraisal of genetics services is usually limited to consideration of financial costs and benefits, but this can generate misunder-standings about the aims of these services. We propose a general framework for economic analysis that includes non-financial costs and benefits, and the concept of genetic fitness.Keywords
This publication has 11 references indexed in Scilit:
- Prenatal diagnosis and genetic screening. Community and service implications. Summary and recommendations of a report of the Royal College of Physicians.1989
- An economic appraisal of screening for Down's syndrome in pregnancy using maternal age and serum alpha fetoprotein concentrationSocial Science & Medicine, 1987
- FIRST-TRIMESTER FETAL DIAGNOSIS FOR HAEMOGLOBINOPATHIES: REPORT ON 200 CASESThe Lancet, 1986
- Cost-benefit analysis of a thalassemia disease prevention program.American Journal of Public Health, 1985
- Measuring the benefits of screening for open neural tube defects.Journal of Epidemiology and Community Health, 1982
- A cost-benefit analysis of prenatal detection of down syndrome and neural tube defects in older mothersAmerican Journal of Medical Genetics, 1981
- Effect of introducing antenatal diagnosis on reproductive behaviour of families at risk for thalassaemia major.BMJ, 1980
- HUMAN BENEFITS AND COSTS OF A NATIONAL SCREENING PROGRAMME FOR NEURAL-TUBE DEFECTSThe Lancet, 1978
- Preventing the birth of infants with Down's syndrome: a cost-benefit analysis.BMJ, 1976
- The Short-Term Reduction in Birth Incidence of Recessive Diseases as a Result of Genetic Counselling after the Birth of an Affected ChildHuman Heredity, 1972